Feedback on the European Unions Council Framework Decision
We acknowledge the EUs efforts to harmonize responses to drug-related offenses but believe the framework requires significant modernization to align with contemporary evidence, economic rationality, and human rights principles
The Institute for Rational Addiction Policy welcomes the opportunity to provide feedback on the European Unions Council Framework Decision 2004/757/JHA.
We acknowledge the EUs efforts to harmonize responses to drug-related offenses but believe the framework requires significant modernization to align with contemporary evidence, economic rationality, and human rights principles.
1. Outdated Paradigm and the Need for Evidence-Based Policies
The existing framework reflects a prohibition-based model rooted in outdated approaches. This model undermines the flexibility of member states to implement evidence-based strategies, such as substance regulation based on harm potential. Countries like Portugal and Switzerland have demonstrated the success of harm reduction and legal regulation in reducing overdose deaths, improving health outcomes, and decreasing law enforcement costs.
2. Economic Inefficiencies of Prohibition
Prohibition imposes substantial costs on member states through law enforcement, incarceration, and lost opportunities for tax revenue from regulated markets. Legal regulation of substances with low harm potentialsuch as cannabis, MDMA, and certain psychedelicsoffers an opportunity to redirect resources toward prevention and treatment while generating public funds to support these programs.
3. Flexibility for National Contexts
The rigid structure of the current framework prevents member states from tailoring policies to their unique contexts. Empowering nations to adopt evidence-based measures that address their specific needs would promote innovation and lead to better outcomes across the EU.
4. Alignment with Public Health and Human Rights Standards
The prohibition approach contributes to stigma, deterring individuals from accessing harm reduction services and exacerbating public health challenges. A modernized framework should prioritize public health, human rights, and harm reduction, aligning with the UN System Common Position on Drugs (2018).
We urge the EU to revise the Framework Decision to empower member states to adopt proportionate, evidence-based drug policies that reflect contemporary realities. A shift toward regulation and harm reduction will ensure policies are effective, humane, and economically sound, benefiting individuals, communities, and public health systems across the EU.
Sincerely, Jana Michailidu, Director of Expert Section, Institute for Rational Addiction Policy
